Wednesday, May 08, 2024 Congratulation to CCTG's very own Dr. Philippe Jamme who was presented the Elizabeth Eisenhauer Early Drug Development Young Investigator Award for his IND study contributions. The award was presented at the CCTG Spring Meeting this past weekend.“Thank you sincerely for this esteemed recognition of the Elizabeth Eisenhauer Early Drug Development Young Investigator Award. It's a profound honor to receive this prize and I am deeply grateful for the opportunity to contribute to the advancement of cancer research and treatment. I humbly accept this award with immense appreciation and dedication to continuing the important work ahead."Dr. Jamme is a medical oncologist whose research focuses on early-phase clinical trials, mechanisms of resistance to targeted therapies and skin cancer. He obtained a PHD (2021) in biology by identifying mechanisms of resistance to targeted therapies in thoracic cancers. Research was carried out at the Lille Biology Institute. From 2019 to 2022, Dr. Jamme was a clinical fellow at the Lille University Hospital (Claude Huriez Hospital) in the department of cutaneous cancers. He has participated as a sub-investigator in numerous phase III trials involving new immunotherapy strategies in advanced melanoma and cutaneous carcinoma. From 2021 to 2023, Dr Philippe Jamme was involved in the development of the early phase oncology unit, as a senior investigator, at the Lille University Hospital (Clinical investigation center, heart-lung institute).
